New Jersey Clawback
IncSmart New Jersey (Small Business and Startups) - Clawbacks, the dirty secret in your pharmacy.  Contracts that pharmacies have with drug-benefit managers, prevent your retailer from exposing fees of less expensive and generic drugs.  Buyers co-pays can be more expensive than if they pay for their product without using the insurance.  YOU MUST ASK YOUR PHARMACIST. 

The fees from less expensive and generic drugs can save you as much as $30 per prescription.  President Donald Trump and his promise to rein in sky rocketing drug costs, will save the government millions of dollars.  We can not forget his famous quote about the pharmaceutical companies getting away with murder.  Lawsuits have already been filed against UnitedHealth Group, Cigna and Humana Inc.  These lawsuits include charges of violating insurance laws, defrauding customers, and racketeering. 
By David Oliver

Starting a Business in New Jersey

For 10 years, Business Services has helped companies and people from all over the world form New Jersey Corporations and New Jersey Limited Liability Companies. When you call, email, text, message or live chat with our office, expect personal attention.  Small business is the heart of IncSmart. 

We are very excited about helping you form your new company.  Each state is so different when it comes to filing documents, you will know right away you are in the right place. 


Think Smart.  Think IncSmart.

Registered Agent Services


Speak with IncSmart
Phone: 888-681-9777
Mon-Fri 8am to 4pm PT



Date 2/24/2017

Isn't Martin Shkreli in jail? He raised the price of Daraprim from $13.50 per pill to $750.


Date 2/25/2017

I just read where an old Enron trader is funding a new formed group called Patients for Affordable Drugs, whose main policy goal is lowering U.S. drug prices. Patients for Affordable Drugs advocates giving Medicare, the government program for the elderly, the ability to negotiate drug prices directly with manufacturers. This is something Big Pharma has long opposed and dreaded. The debate over price negotiating was reignited this year by President Donald Trump, whose administration has said that he might push Congress to allow the government to force drug makers into bidding wars in order to help reduce health-care costs.

Add Comment